08.13.15
Salt Lake City, Utah-based Amedica Corporation, a biomaterial company which makes silicon nitride as a platform for biomedical applications, has earned Brazilian regulatory clearance for its first generation Valeo silicon nitride interbody fusion devices and instrument sets for use in Brazil.
“We are extremely excited to expand our global footprint and have an additional sales channel for our innovative first generation silicon nitride devices,” said Sonny Bal, M.D., J.D., chairman and CEO of Amedica Corporation. “Because our material is the only cleared alternative to PEEK and titanium systems in Brazil, we’ve established increased market interest in our differentiated biomaterial, which offers anti-infective properties and a favorable environment for bone growth. We plan to begin recognizing incremental revenue as early as this quarter now that our first generation is cleared for immediate distribution in Brazil.”
Amedica expects that the clearance and expanded geographic sales footprint will further accelerate adoption of silicon nitride for use in biomedical applications. The company’s next goal is obtaining Brazilian clearance for its second generation Valeo II silicon nitride interbody fusion devices and instrument sets.
Amedica makes medical-grade silicon nitride ceramics.
“We are extremely excited to expand our global footprint and have an additional sales channel for our innovative first generation silicon nitride devices,” said Sonny Bal, M.D., J.D., chairman and CEO of Amedica Corporation. “Because our material is the only cleared alternative to PEEK and titanium systems in Brazil, we’ve established increased market interest in our differentiated biomaterial, which offers anti-infective properties and a favorable environment for bone growth. We plan to begin recognizing incremental revenue as early as this quarter now that our first generation is cleared for immediate distribution in Brazil.”
Amedica expects that the clearance and expanded geographic sales footprint will further accelerate adoption of silicon nitride for use in biomedical applications. The company’s next goal is obtaining Brazilian clearance for its second generation Valeo II silicon nitride interbody fusion devices and instrument sets.
Amedica makes medical-grade silicon nitride ceramics.